Quest Diagnostics looks to get out of antitrust case over allergy testing, immunotherapy
MLex Summary: Quest Diagnostics filed a motion asking that US David A. Ezra to dismiss claims that it conspired to eliminate competition and monopolize the markets for allergy testing and immunotherapy....To view the full article, register now.
Already a subscriber? Click here to view full article